Leucyl aminopeptidases of the M17 class have been considered potential targets for antimalarial drugs [47,48] and with active drug discovery programmes underway [49] new open access drugs will be developed for malaria that could be used against more neglected parasites. The gene discussed is LAP3; the disease is malaria.